Search Options Stock News and Analysis from Schaeffer's

Moderna Eyes FDA Review of Covid-19 Vaccine for Young Children

https://www.schaeffersresearch.com/content/news/2022/05/02/moderna-eyes-fda-review-of-covid-19-vaccine-for-young-children

5/2/2022 9:59 AM

Moderna Inc (NASDAQ:MRNA) is up 5.1% at $141.25 this morning, after the U.S. Food and Drug Administration (FDA) announced an advisory panel of experts will meet in June to review the use of its Covid...

Oil Prices in Focus During Volatile Week

https://www.schaeffersresearch.com/content/news/2022/03/25/oil-prices-in-focus-during-volatile-week

3/25/2022 3:11 PM

It was a mostly back-and-forth week on Wall Street. Monday saw stocks snap their win streaks after comments from U.S. Federal Reserve Chairman Jerome Powell regarding interest rates. It appeared as ...

Moderna Stock Falls Despite Efficacy Update

https://www.schaeffersresearch.com/content/news/2022/03/23/moderna-stock-falls-despite-efficacy-update

3/23/2022 10:35 AM

Moderna Inc (NASDAQ:MRNA) stock is down 4.2% at at $178.82 this morning, after the company released efficacy data for its two-dose Covid-19 vaccine for children under 6 years of age. According to M...

Options Bears Target Moderna Stock Ahead of Earnings Report

https://www.schaeffersresearch.com/content/options/2022/02/23/options-bears-target-moderna-stock-ahead-of-earnings-report

2/23/2022 1:15 PM

The shares of Moderna Inc (NASDAQ:MRNA) are down 4.7% at $138.18 this afternoon, as investors gear up for the vaccine company's fourth-quarter earnings report, due out before the open tomorrow, Feb. ...

Puts Pop on Sinking Moderna Stock

https://www.schaeffersresearch.com/content/options/2022/02/14/puts-pop-on-sinking-moderna-stock

2/14/2022 1:51 PM

Moderna Inc (NASDAQ:MRNA) is down 12.3% at $141.52 this afternoon, following reports that the firm's CEO Stephane Barncel sold 10,000 shares of its stock, amounting to roughly $1.8 million. Barncel di...

PEOPLE ALSO SEARCH FOR

-intraday-options-activity